Delaware Business Court Insider | News
By Ellen Bardash | June 2, 2023
The ruling speaks to a frequently occurring issue, said a lawyer in the case: a lack of transparency between the USPTO and FDA that's allowed those seeking to patent medical devices to make conflicting representations to the two agencies.
By Scott Graham | December 30, 2022
Despite having lost two of its strongest voices on IP in the last two years, the high court is wading into some 'meat and potatoes' IP issues such as pharma patents and copyright fair use.
By Scott Graham | December 22, 2022
Judge Alan Albright's patent docket was slowed but not stopped. Judge Colm Connolly is pulling the lid off of nonpracticing entities. And PTO Director Kathi Vidal "has been everywhere."
By Scott Graham | November 2, 2022
Judge Mitchell Goldberg will let a patent infringement suit against Moderna over COVID-19 vaccine technology proceed in district court. But he left open the possibility that Arbutus Biopharma and Genevant Sciences could ultimately be sent to the Court of Federal Claims.
By Scott Graham | March 15, 2022
A $45 million jury verdict—including $23 million in punitive damages—pushed Natera's stock price down 15% Tuesday while CareDx's climbed 10%.
By Ellen Bardash | September 3, 2021
The case focuses not on a deal being made hastily but on allegations that the CEO of the biotech company now known as 180 Life Sciences Corp. knowingly failed to disclose millions of dollars in liability during its negotiation process last year.
By Ellen Bardash | June 17, 2021
A case filed in Delaware Superior Court is the first anywhere to claim Aziyo Inc. was negligent in sending out a bone marrow product thought to be contaminated with tuberculosis, but attorneys for the Delaware plaintiff say similar cases are expected to be filed soon.
By Tom McParland | April 10, 2019
In a complaint filed Wednesday morning, attorneys for CareDx said Natera, which is based in San Carlos, California, was using a flawed study to launch a "false marketing campaign,"
By Scott Graham | November 15, 2018
A Delaware jury found that 10x Genomics infringed all seven asserted claims related to droplet microfluidic technology.
By Jonathan Ringel | February 21, 2018
Bako's lawyers spent one sentence denying that the Delaware law voided the noncompete agreements and then offered pages of details of “gross misconduct” on which their counterclaims for breach of duty of loyalty, unjust enrichment and defamation are based.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS